Skip to content
Home›Industries›Manufacturing›Chemical Manufacturing›Pharmaceutical & Medicine Manufacturing›Biological Product (Except Diagnostic) Manufacturing
NAICS 325414

Biological Product (Except Diagnostic) Manufacturing

Key Figures

Establishments
441
Census CBP · 2023
Employment
75,198
Census CBP · 2023
Market size
$47.3B
Census Economic Census · 2022

Figures are published for NAICS 325414 directly.

Get the numbers now
Data Pack $99 · 7-page PDF · instant download · snapshot 325414-2026-07-29
Revenue, establishments, jobs and payroll with their history, 35 states ranked, and the share held by the largest firms. No written analysis.
Need the analysis too?
We write a report for this code: Basic $299 · Standard $499 · delivered within 48 hours
Request a report

Secure payments powered by Stripe, a PCI DSS Level 1 certified provider

Official definition

This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).

Source: US Census Bureau, 2017 NAICS Definitions. Public domain.

Which code does this activity belong in?

Code 325414 covers establishments manufacturing biological products derived from plant or animal sources, including vaccines, toxoids, blood fractions, and culture media, but excluding diagnostic substances. The key distinction from 325412 is that 325412 covers pharmaceutical preparations made from chemical compounds formulated into dose forms, whereas 325414 specifically addresses biological products created from living organisms or their components. Code 325413 is excluded because it covers diagnostic substances used in laboratory testing, whereas 325414 encompasses biological products intended for therapeutic use within or on the body.

VantaInsights Analysis AI-drafted

Where this sits

Related classifications